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ABSTRACT
Background: Patients’ beliefs and attitudes toward a treatment can affect treatment response.
In unblinded trials this can affect outcomes.
Aims: The aim of this analysis was to examine the association between treatment preference
and expectation and outcome in a trial of pain treatments.
Methods: In a randomized trial (ISRCTN67013851) of four treatments for chronic widespread
pain, participants were asked which they would prefer and what improvement they expect
from each. The proportion of participants reporting positive health outcomes at three time
points after treatment were compared between those matched or unmatched with their
preference and between those with and without expectation for improvement. Odds ratios
were calculated adjusted for baseline characteristics associated with preference and
expectation.
Results: Four hundred forty-two participants were recruited to the trial (69.5% female). The
proportion reporting positive outcomes among participants matched to their preference
compared to those unmatched was 33.3% vs. 34.4% at the end of treatment (adjusted odds
ratio [aOR] = 0.80, 95% confidence interval [CI], 0.44–1.46), 34.4% vs. 29.0% at 3 months
(aOR = 1.23, 95% CI, 0.67–2.26), and 34.8% vs. 30.3% at 2 years (aOR = 1.31, 95% CI, 0.70–
2.46). The proportion of participants reporting positive outcomes among those expecting
improvement compared to those not expecting improvement was 36.6% vs. 15.0% at the
end of treatment (aOR = 2.03, 95% CI, 1.07–3.85), 34.1% vs. 13.2% at 3 months (aOR = 2.31,
95% CI, 1.22–4.38), and 32.8% vs. 19.1% at 2 years (aOR = 1.16, 95% CI, 0.67–2.36).
Conclusions: Treatment preference had no clear effect on outcomes, but expectation did.
These results could inform future approaches to management, and researchers assessing
treatments should take into account this expectation effect.
RÉSUMÉ
Contexte: Les croyances et les attitudes des patients à l’égard d’un traitement peuvent
influencer la réponse à ce traitement. Dans des essais sans insu, il peut y avoir un effet sur
les résultats.
Buts: Le but de cette analyse était d’étudier le lien entre les préférences et les attentes à
l’égard du traitement, et le résultat obtenu dans un essai portant sur les traitements de la
douleur.
Méthodes: Dans un essai randomisé (ISRCTN67013851) portant sur quatre traitements pour la
douleur chronique généralisée, on a demandé aux participants quelle était leur préférence
quant au traitement, ainsi que l’amélioration qu’ils attendaient de chacun de ces traitements.
Une comparaison de la proportion de participants ayant rapporté des résultats positifs sur leur
santé à trois moments différents après le traitement a été effectuée entre ceux qui ont reçu le
traitement qu’ils préféraient et ceux qui ont reçu un traitement autre que celui qu’ils
préféraient, ainsi qu’entre ceux qui s’attendaient à une amélioration et ceux qui n’avaient
pas de telles attentes. Les rapports de cotes ont été calculés et ajustés selon les
caractéristiques de départ en ce qui concerne la préférence et les attentes.
Résultats: Le nombre de participants recrutés pour cet essai était de 442 (69,5 % de femmes). La
proportion de participants ayant rapporté un résultat positif parmi ceux qui ont reçu le traitement
qu’ils préféraient comparativement à ceux qui ont reçu un traitement autre que celui qu’ils
préféraient était de 33,3 % comparativement à 34,4 % à la fin du traitement (RC ajusté 0,80, 95 %
IC 0,44-1,46); de 34,4% comparativement à 29,0% après troismois (RCa 1,23, 0,67 – 2,26) et de 34,8%
comparativement à 30,3% après deux ans (RCa 1,31, 0,70 – 2,46). La proportion de participants ayant
rapporté des résultats positifs parmi ceux qui s’attendaient à une amélioration comparativement à
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ceux qui n’avaient pas de telles attentes était de 36,6 % comparativement à 15,0 % à la fin du
traitement (RCa 2,03, 1,07-3,85), de 34,1% comparativement à 13,2% après troismois (RCa 2,31, 1,22-
4,38), et de 32,8 % comparativement à 19,1 % après deux ans (RCa 1,16, 0,67-2,36).
Conclusions: La préférence en matière de traitement n’a pas eu d’effet clair sur les résultats,
contrairement aux attentes. Ces résultats pourraient inspirer les approches futures en matière
de prise en charge, tandis que les chercheurs qui évaluent des traitements devraient tenir
compte de l’effet des attentes.
Introduction
When a patient receiving treatment for pain gets better,
he or she might have done so through specific hypothe-
sized mechanisms arising from the treatment. However,
there are other reasons why a treatment might appear
to work. The natural history of the condition may be
such that symptoms resolve without treatment.
Regression to the mean happens when we select people
at a time when they are at an extreme on some mea-
surement and only measure outcomes in those people.
Some components of a treatment are not specific to
that treatment but instead are common to many, such
as attention from a medical practitioner,1 so effects due
to these components cannot be uniquely ascribed to the
treatment. Finally, there is a collection of effects that
are due to the beliefs a patient has about the treatment.
These can include the expectancy that the treatment
will have an effect and preference for one treatment
over another. As well as direct effects that beliefs and
attitudes have on outcomes, these factors may induce
demand characteristics in self-reported answers to
questions such as, “Do you feel better?” which might
bias responses.
When we look at all these together—natural history,
regression, common factors, treatment beliefs, demand
characteristics—it could be said that we are looking at
the placebo response, a response that is not due to the
effect of treatment.2 Only once these components of the
placebo response have been accounted for can we say
whether we have discovered a specific treatment effect
or not. This is one reason for conducting randomized
trials comparing outcomes between people receiving a
treatment and those not receiving the treatment. In
such trials, participants are randomly allocated to either
a group receiving the treatment of interest or a control
group not receiving that treatment (though they may be
receiving an active treatment for comparison or a treat-
ment that is thought to be inert). People in the control
group may get better for reasons other than the treat-
ment, but any response in the treatment group over
and above that in the control group can be attributed to
the treatment. However, this only applies when the two
groups do not differ with respect to all factors thought
to comprise the placebo effect, including beliefs and
expectations the participant has about the treatment,
as well as artefacts such as regression to the mean. In
unblinded trials, participants know whether they are in
a control group or whether they are receiving a treat-
ment. In an unblinded trial comparing two or more
active treatments, participants may have differing
expectations for the effectiveness of the treatments
and may have a preference for one of them.
Preference for a particular treatment has been noted
as a potential threat to the validity of unblinded trials,3
and the effects of expectation on pain have been well
documented.4,5 One example of the effect of expecta-
tion in an experimental setting is analgesia induced by
the use of an inert cream with healthy subjects who
believe it to be an effective treatment for pain.6
Prior to allocation to a treatment group in a rando-
mized trial, information can be collected from partici-
pants about which treatment they would prefer and also
about the outcome they would expect from each of the
treatments. Then it is possible to see whether outcomes
differ according to whether or not participants received
their preferred treatment and whether or not they had
high expectations for the treatment they received. The
MUSICIAN Study is one such randomized trial that has
previously reported effective treatments for pain7,8 and
that collected information on preference and expecta-
tions. The aim of the current analysis was to see whether
patient-reported improvement in health (the main out-
come) in a randomized trial for cognitive–behavioral
therapy (CBT), exercise, or both treatments for patients
with chronic widespread pain (CWP) was associated with
nonspecific factors of treatment, namely, whether partici-
pants received the treatment they preferred and whether
they expected improvement for the treatment they
received.
Materials and methods
The MUSICIAN Study was a 2 × 2 randomised trial of
CBT or exercise for people with CWP. The full details and
results have been reported previously.7–9 The trial com-
pared three active treatment arms—a CBT program deliv-
ered by telephone (tCBT), an exercise program, or both
exercise and tCBT delivered simultaneously versus
162 M. J. BEASLEY ET AL.
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treatment as usual (TAU). The tCBT consisted of an
initial assessment by telephone with a therapist, followed
by seven weekly sessions and follow-up sessions at 3 and
6 months. The exercise program was conducted at a
leisure facility gym and was led by a fitness instructor
with whom participants could meet once a month.8 A
screening survey of patients registered at selected doctors’
practices in two areas of the UK, with approximately 15
000 respondents, was used to identify and recruit 442
participants. Eligible participants reported CWP (accord-
ing to the definition in the American College of
Rheumatology criteria for fibromyalgia)10 for which they
had consulted their general practitioner. Participants were
at least 25 years old, and exclusion criteria included con-
traindications to exercise and psychiatric disorder.8
Confirmation of eligibility for the study and treatment
allocation was conducted at clinic visits with a research
nurse. The study received full ethical approval from the
Cheshire Research Ethics Committee (reference number:
07/Q1506/61), the trial registration number was
ISRCTN67013851, and all participants gave informed
consent.
Measures
Participants were randomly allocated to one of the
three active treatments (tCBT, exercise, or both com-
bined) or TAU. Immediately before treatment alloca-
tion, participants were asked, “If you had to choose the
treatment(s) to have which would you choose?”
Participants could select one answer from a list of
five: cognitive–behavioral therapy alone, exercise ther-
apy alone, both treatments, no preference, or don’t
know. Those who were subsequently allocated to their
preferred treatment were classed as matched, and those
who were allocated to a treatment other than their
stated preference were classed as unmatched. Because
the aim of this analysis was to examine the effects of
receiving a preferred treatment, those with no prefer-
ence were also allocated to the unmatched group
because they could not be said to have received their
preferred treatment if they did not have one. For two
additional sensitivity analyses, participants who did not
have a treatment preference were first removed from
the unmatched group and secondly included in the
matched group.
Participants were also asked four questions before allo-
cation: “If you receive cognitive–behavioral therapy only,
how do you think this will affect your pain after 6 months
of treatment?” with “exercise therapy only,” “both exercise
and cognitive–behavioral therapy,” or “neither therapy
(i.e., receive the usual care given by your general practi-
tioner)” substituted for “cognitive–behavioral therapy
only.” Participants could select one answer from a list of
five for each question: “It would be much improved,” “It
would be a little improved,” “It would be neither better nor
worse,” “It would be a little worse,” or “It would be much
worse.” Participants were classed as having had an expecta-
tion of improved if the response was, “It would be much
improved” or “It would be a little improved” for the treat-
ment to which they were subsequently allocated and
classed as no change or worse otherwise.
The following baseline characteristics were also col-
lected prior to treatment allocation: age, gender,
Chronic Pain Grade (CPG),11 passive and active coping
measured by the Vanderbilt Pain Management
Inventory,12 the Chalder Fatigue Scale,13 psychological
distress (measured by the General Health Questionnaire
[GHQ]-12),14 the Sleep Problem Scale,15 and the Tampa
Scale for Kinesiophobia.16 Where single item responses
were missing on any of these scales, scores for that item
were imputed as themean score of the other items for that
measure.
The main outcome measure of the trial was patient-
reported improvement in global health, on a seven-
point scale ranging from very much better through no
change to very much worse. The main outcome was
collected at three time points: at the end of treatment
and 3 months and 2 years after the end of treatment.
Responses were dichotomized with very much better or
much better classed as a positive outcome.
Statistical methods
First, associations of treatment preference and expecta-
tion with baseline characteristics were identified in order
to use as adjusting factors when looking at their associa-
tions with outcomes. Differences in gender and CPG by
treatment preference were tested with chi-square tests.
The other baseline characteristics were treated as contin-
uous and differences by preference were tested with ana-
lysis of variance. Where a difference was found, Tukey’s
honestly significant difference was used to identify which
preferences differed, and the difference in scores are
reported with 95% confidence intervals (CIs).
Differences in proportions of genders and CPG with
expectations of improvement or no change or worse for
each treatment were tested with chi-square tests. We used
t tests to test for differences in baseline characteristics for
those expecting improvement or no change or worse for
each treatment, and where differences were found they
are reported with 95% CIs.
The proportion of participants reporting a positive
outcome (much better or very much better) among
those matched to their treatment preference was com-
pared to those unmatched among all those allocated to
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active treatment at all time points and then for each
treatment group separately. Participants allocated to
TAU were not included in this analysis, because the
option was not given in the question eliciting treatment
preference. Logistic regression was used to calculate
odds ratios with 95% CIs of a positive outcome in
those matched compared to those unmatched. Odds
ratios were then adjusted for baseline factors associated
with treatment preference. Two sensitivity analyses
were conducted, firstly removing those without any
treatment preference from the unmatched group and,
secondly, including those without a preference in the
matched group.
The proportion of participants with a positive out-
come among those with an expectation of improvement
for the treatment they received was compared to those
without among all participants at all time points and
then for each treatment group separately. Logistic
regression was also used to calculate odds ratios with
95% CIs of positive outcome in those with expectations
of improvement for the treatment to which they were
allocated, compared to those without. Odds ratios were
then adjusted for baseline characteristics associated
with expectations of improvement for a particular
treatment.
Results
Treatment preference
Combined CBT and exercise was the most preferred of
the active treatments, with 199 participants (45.0%)
choosing this treatment prior to allocation (Table 1).
CBT alone was the least preferred treatment, with only
20 participants (4.5%) choosing this treatment.
Participants choosing different treatments differed on
a number of baseline characteristics. Exercise alone was
the preferred treatment for males, with 59 (43.7%)
choosing this, whereas combined CBT and exercise
was the preferred treatment for females, with 152
(49.5%) choosing this option. Those who preferred
CBT alone had higher scores than those who preferred
exercise alone for psychological distress (4.7 vs. 2.3,
difference 2.3, 95% CI, 0.8–3.8), passive coping (34.0
vs. 27.6, difference 6.4, 95% CI, 3.0–9.7), sleep problems
(11.6 vs. 8.1, difference 3.5, 95% CI, 1.0–6.1), fatigue
(22.4 vs. 18.4, difference 4.0, 95% CI, 1.6–6.5), and
kinesiophobia (38.8 vs. 35.1, difference 3.7, 95% CI,
1.0–6.3). Those preferring CBT alone also had higher
scores than those preferring combined CBT and exer-
cise for passive coping (34.0 vs. 30.0, difference 4.0,
95% CI, 0.7–7.2) and kinesiophobia (38.8 vs. 36.0, dif-
ference 2.7, 95% CI, 0.3–5.2).
There was no clear association between being
matched to a preferred treatment group and achieving
a positive outcome (Tables 2a–2c). The proportion of
participants with a positive outcome at all time points
was similar among those who were matched to their
preferred treatment and those who were unmatched:
33.3% vs. 34.4% at the end of treatment (adjusted odds
ratio [aOR] = 0.80, 95% CI, 0.44–1.46), 34.4% vs. 29.0%
at 3 months after the end of treatment (aOR = 1.23,
95% CI, 0.67–2.26), and 34.8% vs. 30.3% at 2 years
(aOR = 1.31, 95% CI, 0.70–2.46).
The sensitivity analyses similarly showed no clear
association between being matched to a preferred treat-
ment group and outcomes. The proportions reporting a
positive outcome among those matched to their pre-
ferred treatment compared to those not, excluding
those with no treatment preference, was 33.3% vs.
35.9% at the end of treatment (aOR = 0.83, 95% CI,
0.43–1.63), 34.4% vs. 31.9% at 3 months after the end of
treatment (aOR = 1.16, 95% CI, 0.59–2.26), and 34.8%
vs. 30.5% at 2 years (aOR = 1.14, 95% CI, 0.57–2.30).
The proportion reporting a positive outcome among
those matched compared to those not, including those
with no preference in the matched group, was 32.4% vs.
35.9% at the end of treatment (aOR = 0.72, 95% CI,
Table 1. Characteristics by treatment preference.
Preferred treatment
CBT Exercise Both treatments No preference P value
n (%) 20 (4.5) 144 (32.6) 199 (45.0) 79 (17.9)
Age, mean (SD) 52.9 (14.0) 57.4 (13.1) 55.4 (13.1) 57.1 (12.7) ns
Gender Males (%) 6 (4.4) 59 (43.7) 47 (34.8) 23 (17.0) <0.01
Females (%) 14 (4.6) 85 (27.7) 152 (49.5) 56 (18.2)
CPG Grades 1 or 2 (%) 10 (3.8) 94 (35.3) 120 (45.1) 42 (15.8) ns
Grades 3 or 4 (%) 10 (5.7) 50 (28.4) 79 (44.8) 37 (21.0)
GHQ 12, mean (SD) 4.7 (4.2) 2.3 (3.0) 3.7 (3.7) 3.3 (3.7) <0.01
Passive coping, mean (SD) 34.0 (5.9) 27.6 (7.2) 30.0 (7.2) 30.4 (7.8) <0.01
Active coping, mean (SD) 23.6 (3.7) 24.9 (4.6) 25.1 (4.1) 24.6 (4.0) ns
Sleep problems, mean (SD) 11.6 (5.8) 8.1 (5.3) 9.4 (5.7) 10.1 (5.6) <0.01
Fatigue, mean (SD) 22.4 (7.5) 18.4 (4.9) 20.2 (5.9) 20.4 (6.6) <0.01
Kinesiophobia, mean (SD) 38.8 (8.6) 35.1 (5.1) 36.0 (4.8) 35.7 (5.7) 0.03
CBT = cognitive–behavioral therapy; ns = not significant; CPG = Chronic Pain Grade; GHQ = General Health Questionnaire.
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0.41–1.26), 29.8% vs. 31.9% at 3 months after the end of
treatment (aOR = 0.79, 95% CI, 0.45–1.39), and 33.1%
vs. 30.5% at 2 years (aOR = 1.16, 95% CI, 0.64–2.10).
Expectation
Combined CBT and exercise had the highest expecta-
tion of improvement, with 355 participants (80.3%)
expecting an improvement in pain after 6 months of
this treatment (Table 3). Usual care had the lowest
expectation of improvement, with 41 participants
(9.3%) expecting to be improved. Those expecting
improvement from CBT had higher psychological dis-
tress than those not expecting improvement (3.8 vs. 2.6,
difference 1.1, 95% CI, 0.5–1.8). A greater proportion
of those with low CPG expected improvement from
exercise compared to those with a high CPG (81.6%
vs. 72.7%). Those expecting improvement from exercise
compared to those not expecting improvement had
lower passive coping (28.8 vs. 31.6, difference −2.8,
95% CI, −4.5 to −1.2) and lower kinesiophobia (35.1
vs. 38.2, difference −3.1, 95% CI, −4.3 to −1.9). Females
were more likely to expect improvement from com-
bined CBT and exercise treatment than males (83.1%
vs. 74.1%). Those with low CPG were more likely to
expect improvement from combined treatment than
those with high CPG (83.5% vs. 75.6%). Those expect-
ing improvement from combined treatment also had
lower levels of passive coping than those not expecting
improvement (29.0 vs. 31.2, difference −2.2, 95% CI,
−3.9 to −0.48) and kinesiophobia (35.2 vs. 38.0, differ-
ence −2.9, 95% CI, −4.1 to −1.6).
There was an increased odds of a positive outcome
among participants who had an expectation of improve-
ment for the treatment to which they were allocated
compared to those not (Tables 4a–4c) at the end of
Table 2a. Outcomes at end of treatment by being matched to preferred treatment.
Preference Positive outcome Negative outcome OR Adjusted ORa Adjusted for treatment ORb
All active treatments (n = 273) Matched 31 (33.3) 62 (66.7) 0.95 (0.56–1.62) 0.93 (0.54–1.62) 0.80 (0.44–1.46)
Unmatched 62 (34.4) 118 (65.6) 1 (Ref) 1 (Ref) 1 (Ref)
tCBT (n = 87) Matched 2 (33.3) 4 (66.7) 1.19 (0.20–6.92) 1.13 (0.15–8.30)
Unmatched 24 (29.6) 57 (70.4) 1 (Ref) 1 (Ref)
Exercise (n = 92) Matched 12 (33.3) 24 (66.7) 0.90 (0.37–2.18) 0.65 (0.23–1.86)
Unmatched 20 (35.7) 36 (64.3) 1 (Ref) 1 (Ref)
Combined (n = 94) Matched 17 (33.3) 34 (66.7) 0.69 (0.30–1.61) 0.69 (0.28–1.72)
Unmatched 18 (41.9) 25 (58.1) 1 (Ref) 1 (Ref)
aAdjusted for gender, GHQ scores, passive coping, sleep problems, Chalder fatigue scores, and kinesiophobia.
bAdditionally adjusted for treatment group.
OR = odds ratio; tCBT, telephone-delivered cognitive–behavioral therapy; GHQ = General Health Questionnaire.
Table 2b. Outcomes at 3 months by being matched to preferred treatment.
Expectation Positive outcome Negative outcome OR Adjusted ORa Adjusted for treatment ORb
All active treatments (n = 289) Matched 33 (34.4) 63 (65.6) 1.28 (0.76–2.16) 1.17 (0.67–2.03) 1.23 (0.67–2.26)
Unmatched 56 (29.0) 137 (71.0) 1 (Ref) 1 (Ref)
tCBT (n = 89) Matched 4 (66.7) 2 (33.3) 4.64 (0.80–27.00) 7.73 (0.98–60.67)
Unmatched 25 (30.1) 58 (69.9) 1 (Ref) 1 (Ref)
Exercise (n = 99) Matched 10 (26.3) 28 (73.7) 1.20 (0.47–3.06) 1.28 (0.43–3.84)
Unmatched 14 (23.0) 47 (77.1) 1 (Ref) 1 (Ref)
Combined (n = 101) Matched 19 (36.5) 33 (63.5) 1.08 (0.48–2.45) 0.96 (0.39–2.37)
Unmatched 17 (34.7) 32 (65.3) 1 (Ref) 1 (Ref)
aAdjusted for gender, GHQ scores, passive coping, sleep problems, Chalder fatigue scores, and kinesiophobia.
bAdditionally adjusted for treatment group.
OR = odds ratio; tCBT, telephone-delivered cognitive–behavioral therapy; GHQ = General Health Questionnaire.
Table 2c. Outcomes at 2 years by being matched to preferred treatment.
Preference Positive outcome Negative outcome OR Adjusted ORa Adjusted for treatment ORb
All active treatments (n = 267) Matched 31 (34.8) 58 (65.2) 1.23 (0.71–2.11) 1.12 (0.63–1.99) 1.31 (0.70–2.46)
Unmatched 54 (30.3) 124 (69.7) 1 (Ref) 1 (Ref)
tCBT (n = 82) Matched 1 (16.7) 5 (83.3) 0.34 (0.04–3.09) 0.29 (0.03–3.08)
Unmatched 28 (36.8) 48 (63.2) 1 (Ref) 1 (Ref)
Exercise (n = 92) Matched 13 (37.1) 22 (62.9) 1.81 (0.73–4.52) 1.54 (0.53–4.49)
Unmatched 14 (24.6) 43 (75.4) 1 (Ref) 1 (Ref)
Combined (n = 93) Matched 17 (35.4) 31 (64.6) 1.51 (0.62–3.66) 1.12 (0.39–3.18)
Unmatched 12 (26.7) 33 (73.3) 1 (Ref) 1 (Ref)
aAdjusted for gender, GHQ scores, passive coping, sleep problems, Chalder fatigue scores, and kinesiophobia.
bAdditionally adjusted for treatment group.
OR = odds ratio; tCBT, telephone-delivered cognitive–behavioral therapy; GHQ = General Health Questionnaire.
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Table 4a. Outcomes at end of treatment by treatment expectation.
Expectation Positive outcome Negative outcome OR Adjusted OR Adjusted for treatment OR
All (n = 360) Improved 78 (36.6) 135 (63.4) 3.28 (1.93–5.59) 3.41a (1.97–5.89) 2.03b (1.07–3.85)
No change or worse 22 (15.0) 125 (85.0) 1 (Ref) 1 (Ref) 1 (Ref)
tCBT (n = 87) Improved 19 (40.4) 28 (59.6) 3.20 (1.17–8.72) 2.95c (1.05–8.30)
No change or worse 7 (17.5) 33 (82.5) 1 (Ref) 1 (Ref)
Exercise (n = 92) Improved 26 (37.1) 44 (62.9) 1.58 (0.55–4.53) 1.80d (0.57–5.74)
No change or worse 6 (27.3) 16 (72.7) 1 (Ref) 1 (Ref)
Combined (n = 94) Improved 32 (38.1) 52 (61.9) 1.44 (0.35–5.95) 1.66e (0.34–8.08)
No change or worse 3 (30.0) 7 (70.0) 1 (Ref) 1 (Ref)
TAU (n = 87) Improved 1 (8.3) 11 (91.7) 1.04 (0.11–9.54) —
No change or worse 6 (8.0) 69 (92.0) 1 (Ref) —
aAdjusted for gender, GHQ scores, CPG, passive coping, and kinesiophobia.
bAdjusted for gender, GHQ scores, CPG, passive coping, kinesiophobia, and treatment group.
cAdjusted for GHQ scores.
dAdjusted for CPG, passive coping, and kinesiophobia.
eAdjusted for gender, CPG, passive coping, and kinesiophobia.
OR = odds ratio; tCBT = telephone-delivered cognitive–behavioral therapy; TAU = treatment as usual; GHQ = General Health Questionnaire; CPG = Chronic
Pain Grade.
Table 3. Characteristics of those with expectations of improvement for each treatment.
Expectation
No change or worse Improved P value
CBT Number of participants (%) 215 (48.6) 227 (51.4)
Age, mean (SD) 56.7 (13.1) 55.8 (13.0) ns
Gender Males (%) 75 (55.6) 60 (44.4) ns
Females (%) 140 (45.6) 167 (54.4)
CPG 1 or 2 (%) 134 (50.4) 132 (49.6) ns
3 or 4 (%) 81 (46.0) 95 (54.0)
GHQ, mean (SD) 2.6 (3.3) 3.8 (3.7) <0.01
Passive coping, mean (SD) 36.2 (5.1) 35.4 (5.5) ns
Active coping, mean (SD) 28.8 (7.7) 30.1 (7.1) ns
Sleep problems, mean (SD) 9.0 (5.8) 9.4 (5.4) ns
Fatigue, mean (SD) 19.3 (5.5) 20.2 (6.2) ns
Kinesiophobia, mean (SD) 36.2 (5.1) 35.4 (5.5) ns
Exercise Number of participants (%) 97 (21.9) 345 (78.1)
Age, mean (SD) 57.6 (13.1) 55.9 (13.0) ns
Gender Male (%) 31 (23.0) 104 (77.0) ns
Female (%) 66 (21.5) 241 (78.5)
CPG 1 or 2 (%) 49 (18.4) 217 (81.6) 0.03
3 or 4 (%) 48 (27.3) 128 (72.7)
GHQ, mean (SD) 3.3 (3.7) 3.2 (3.5) ns
Passive coping, mean (SD) 31.6 (8.3) 28.8 (7.0) <0.01
Active coping, mean (SD) 24.4 (4.5) 25.0 (4.1) ns
Sleep problems, mean (SD) 10.0 (6.1) 9.0 (5.4) ns
Fatigue, mean (SD) 20.5 (5.8) 19.5 (5.9) ns
Kinesiophobia, mean (SD) 38.2 (5.8) 35.1 (5.0) <0.01
Both treatments Number of participants (%) 87 (19.7) 355 (80.3)
Age, mean (SD) 57.8 55.9 ns
Gender Male (%) 35 (25.9) 100 (74.1) 0.03
Female (%) 52 (16.9) 255 (83.1)
CPG 1 or 2 (%) 44 (16.5) 222 (83.5) 0.04
3 or 4 (%) 43 (24.4) 133 (75.6)
GHQ 12, mean (SD) 3.2 (3.7) 3.2 (3.5) ns
Passive coping, mean (SD) 31.2 (8.9) 29.0 (6.9) 0.01
Active coping, mean (SD) 24.4 (4.8) 25.0 (4.1) ns
Sleep problems, mean (SD) 9.6 (6.3) 9.1 (5.4) ns
Fatigue, mean (SD) 20.1 (5.7) 19.7 (5.9) ns
Kinesiophobia, mean (SD) 38.0 (5.9) 35.2 (5.0) <0.01
Usual care Number of participants (%) 401 (90.7) 41 (9.3)
Age, mean (SD) 56.3 (13.2) 55.4 (11.8) ns
Gender Male (%) 118 (87.4) 17 (12.6) ns
Female (%) 283 (92.2) 24 (7.8)
CPG 1 or 2 (%) 245 (92.1) 21 (7.9) ns
3 or 4 (%) 156 (88.6) 20 (11.4)
GHQ 12, mean (SD) 3.2 (3.5) 2.9 (3.7) ns
Passive coping, mean (SD) 29.3 (7.3) 30.5 (7.9) ns
Active coping, mean (SD) 24.9 (4.2) 24.3 (4.7) ns
Sleep problems, mean (SD) 9.2 (5.5) 9.1 (6.5) ns
Fatigue, mean (SD) 19.9 (5.8) 18.8 (6.4) ns
Kinesiophobia, mean (SD) 35.8 (5.2) 35.6 (6.7) ns
CBT = cognitive–behavioral therapy; ns = not significant; CPG = Chronic Pain Grade; GHQ = General Health Questionnaire.
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treatment (36.6% vs. 15.0%, aOR = 2.03, 95% CI, 1.07–
3.85) and 3 months later (34.1% vs. 13.2%, aOR = 2.31,
95% CI, 1.22–4.38). For those receiving CBT, there was
increased odds of reporting a positive outcome in those
with an expectation of improvement compared to those
not at the end of treatment (40.4% vs. 17.5%, aOR = 2.95,
95% CI, 1.05–8.30) and 3 months later (47.8% vs. 16.3%,
aOR = 4.52, 95% CI, 1.65–12.39). For those receiving
exercise alone, there was an increased odds of reporting
a positive outcome in those with an expectation of
improvement compared to those not 3 months after the
end of treatment (29.3% vs. 8.3%, aOR = 4.52, 95% CI,
1.09–27.2).
Discussion
This secondary analysis of the results from a trial of
treatments for patients with CWP found that partici-
pants who were randomly allocated to their preferred
treatment did no better than those who were not. It also
found that participants who had a prior expectation for
improvement from the treatment group to which they
were allocated did do better than those who did not
expect improvement. This was particularly so for those
allocated to CBT treatment, and particularly at the end
of treatment and 3 months after ending treatment. The
effect remained after adjusting for baseline characteris-
tics associated with expectations that might have had an
effect on outcomes. Generally, trial participants had a
greater preference for exercise or for combined exercise
and CBT than for CBT alone. They also had greater
expectation of improvement for these treatments com-
pared to CBT or usual care from a general practitioner.
A strength of this study is that participants were
asked to indicate their preferences and expectations
prior to allocation to treatment, so their choices were
not influenced by the treatment they were eventually
assigned. Likewise, randomization ensured that partici-
pants had no choice over which treatment they
received. The trial, however, was not designed to mea-
sure the effects of patient attitudes toward treatment.
There may have been small effects of preference or
expectation that the trial was not powered to detect.
Table 4b. Outcomes at 3 months by treatment expectation.
Expectation Positive outcome Negative outcome OR Adjusted OR Adjusted for treatment OR
All (n = 387) Improved 75 (34.1) 145 (65.9) 3.41 (2.01–5.78) 3.35a (1.95–5.76) 2.31b (1.22–4.38)
No change or worse 22 (13.2) 145 (86.8) 1 (Ref) 1 (Ref) 1 (Ref)
tCBT (n = 89) Improved 22 (47.8) 24 (52.2) 4.71 (1.74–12.75) 4.52c (1.65–12.39)
No change or worse 7 (16.3) 36 (83.7) 1 (Ref) 1 (Ref)
Exercise (n = 99) Improved 22 (29.3) 53 (70.7) 4.57 (0.99–21.10) 5.43d (1.09–27.2)
No change or worse 2 (8.3) 22 (91.7) 1 (Ref) 1 (Ref)
Combined (n = 101) Improved 31 (35.6) 56 (64.4) 1.00 (0.31–3.24) 0.67e (0.18–2.48)
No change or worse 5 (35.7) 9 (64.3) 1 (Ref) 1 (Ref)
TAU (n = 98) Improved 0 (0.0) 12 (100.0) 0.61 (0.00–4.38)* —
No change or worse 8 (9.3) 78 (90.7) 1 (Ref) —
aAdjusted for gender, GHQ scores, CPG, passive coping, and kinesiophobia.
bAdjusted for gender, GHQ scores, CPG, passive coping, kinesiophobia, and treatment group.
cAdjusted for GHQ scores.
dAdjusted for CPG, passive coping, and kinesiophobia.
eAdjusted for gender, CPG, passive coping, and kinesiophobia.
OR = odds ratio; tCBT = telephone-delivered cognitive–behavioral therapy; TAU = treatment as usual; GHQ = General Health Questionnaire; CPG = Chronic
Pain Grade.
Table 4c. Outcomes at 2 years by treatment expectation.
Expectation Positive outcome Negative outcome OR Adjusted OR Adjusted for treatment OR
All (n = 361) Improved 67 (32.8) 137 (67.2) 2.07 (1.26–3.39) 1.85a (1.11–3.07) 1.26b (0.67–2.36)
No change or worse 30 (19.1) 127 (80.9) 1 (Ref) 1 (Ref) 1 (Ref)
tCBT (n = 82) Improved 17 (40.5) 25 (59.5) 1.59 (0.64–3.96) 1.40c (0.54–3.59)
No change or worse 12 (30.0) 28 (70.0) 1 (Ref) 1 (Ref)
Exercise (n = 92) Improved 23 (32.4) 48 (67.6) 2.04 (0.62–6.74) 1.64d (0.47–5.75)
No change or worse 4 (19.1) 17 (81.0) 1 (Ref) 1 (Ref)
Combined (n = 93) Improved 25 (30.9) 56 (69.1) 0.89 (0.25–3.24) 0.64e (0.15–2.67)
No change or worse 4 (33.3) 8 (66.7) 1 (Ref) 1 (Ref)
TAU (n = 94) Improved 2 (20.0) 8 (80.0) 1.85 (0.34–9.97) —
No change or worse 10 (11.9) 74 (88.1) 1 (Ref) —
aAdjusted for gender, GHQ scores, CPG, passive coping, and kinesiophobia.
bAdjusted for gender, GHQ scores, CPG, passive coping, kinesiophobia, and treatment group.
cAdjusted for GHQ scores.
dAdjusted for CPG, passive coping, and kinesiophobia.
eAdjusted for gender, CPG, passive coping, and kinesiophobia.
OR = odds ratio; tCBT = telephone-delivered cognitive–behavioral therapy; TAU = treatment as usual; GHQ = General Health Questionnaire; CPG = Chronic
Pain Grade.
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In particular, there were only a small number of parti-
cipants who had a preference for CBT, so though there
was no overall effect of receiving a preferred treatment,
there may have been a benefit for those who preferred
CBT and received it. In addition, usual care was not
given as an option for participants to choose as a
preference, which means it was not possible to measure
any preference effect among those receiving it. This,
along with the small number of participants choosing
some treatments, meant that interaction effects of pre-
ference and expectation were not examined in this
analysis. And, of course, we did not randomly assign
treatment preferences and expectations to the partici-
pants. Another weakness of the study is that preference
was measured by a single question, to which partici-
pants could only make one response—some partici-
pants may have had equal preference for more than
one treatment option. The preference question also did
not measure strength of preference for or against dif-
ferent treatment options. It is possible that preference
effects might be only be seen in those with strong
preferences. It should also be noted that the question
used to elicit prior expectations of treatment effective-
ness asked about expectations for pain rather than
overall health, which was the main outcome of the
study.
Despite these limitations, the findings of this study
were largely in agreement with previous studies looking
at participants’ preferences in the context of rando-
mized controlled trials for musculoskeletal conditions.
In trials of exercise,17 acupuncture,18 and physical and
behavioral therapies19 for back pain, outcomes were not
associated with receiving preferred treatment. However,
George and Robinson19 did find that those with no
strong treatment preference had better outcomes for
pain and disability than those with a preference.
Additionally, Foster et al.20 found no effect of patients’
treatment preferences in a trial of acupuncture or exer-
cise for knee osteoarthritis, and Stewart et al.21 con-
cluded there was no evidence that preferences
moderated the effect of exercise for chronic whiplash.
These previous studies were looking at conditions other
than CWP and at treatments other than exercise or
CBT, and the questions used to elicit preference
would have been different depending on the design of
the trial. The current study adds to these by showing
that the lack of a preference effect in pain trials is
robust for different patient groups and different meth-
ods of measuring preference.
The current study also adds to a large body of
evidence that suggests that expectations affect outcomes
in randomized trials of pain treatments. In one study,
expectations for a cognitive–behavioral intervention
were found to be associated with outcomes in patients
with fibromyalgia or chronic low back pain.22 In trials
looking at both physical and behavioral therapies for
low back pain, prior expectations for improvement
have been found to be associated with effectiveness of
the treatment19 and disability and satisfaction.23
Expectations have also been shown to be associated
with outcomes in pain trials of acupuncture,18,24,25
massage,24 and paracetamol.26 These studies investi-
gated the effects of expectation on a range of outcomes
for different treatments and conditions using different
methods for measuring expectations, with the
Credibility/Expectancy Questionnaire being a com-
monly used measure.27 What the current study adds
to the existing evidence is some suggestion that the
effect of expectations might differ over time and that
they may be greater for some treatments than for
others.
There are separate implications for clinical practice and
for design of research studies from these results. Whereas
in research we may seek to minimize and rule out effects
due to nonspecific factors such as preference and expecta-
tions to determine the specific mechanisms that make a
treatment work, in clinical practice we may seek to max-
imize these effects to promote better outcomes. Although
we found that preference did not have an effect on out-
comes, it should not be assumed that preference is not an
important factor when choosing treatment for patients
with pain conditions. The context of a participant in a
randomized trial is quite different from that of a patient
visiting a clinician, and we cannot be sure that preference
would not have an effect on outcome in the clinic. In
addition, there are other considerations when deciding on
a treatment other than measurable health outcomes, and it
may still be beneficial to treat patients according to pre-
ference. However, when improvement in overall health
outcomes is a consideration, this does show that patients
will do better when receiving a treatment where they expect
to do better. So clinicians should consider giving pain
patients treatments for which they have higher expecta-
tions. Future treatments for pain that target expectations
for pain should also be explored.28
For designers of research studies who are seeking to
determine treatment effects, preference and expectation
can be considered nuisance factors that should be con-
trolled or adjusted for. The results of this study imply that,
though preference may not have much of an effect on
outcomes, differing expectations for different treatment
arms need to be taken into account. At the very least,
expectation for the effectiveness of treatment a participant
receives in a trial should be measured and reported when
discussing results to aid in their interpretation.29 New
research designs can be used to assess how much of an
168 M. J. BEASLEY ET AL.
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 A
be
rd
ee
n]
 at
 07
:54
 30
 O
cto
be
r 2
01
7 
observed effect is due to expectation and howmuch is due
to specific effects, such as two-stage designs where parti-
cipants are randomized to receive either a randomly cho-
sen treatment or a treatment for which they have higher
expectations.3 And in randomized trials where an active
placebo control group is used as a comparator, they
should be chosen tomatch the treatment group for expec-
tations of effectiveness.30
There are a number of questions left unanswered about
expectation and its effects on outcomes. A first question
would be how best tomeasure it. Another is what outcomes
can be affected by expectation. We also need to be clear
about how it works and whether it can be explained by
reporting bias. Some previous research has shown that
adherence to treatment is not a mediator between expecta-
tion and outcomes,26,31 so other mediators need to identi-
fied. One difficulty lies in not being able to assign
participants randomly to high or low expectations, so
other research designs need to be used. In this study, we
found a number of factors associated with positive or
negative expectations for treatment, in particular, higher
psychological distress among those expecting improvement
from CBT and lower levels of passive coping and kinesio-
phobia among those expecting improvement from exercise.
Future research could examine how expectations for treat-
ment are related to personality factors, previous experience
of treatment, and comorbidities. Another question is
whether expectations can change over the course of treat-
ment and then whether those changed expectations can
affect outcomes or whether changes proceed from rather
than precede changes in outcome. Finally, further research
into treatments that are specifically designed to modify
patients’ expectations of the effectiveness of treatment
should be explored.28
In conclusion, the results of this study demonstrate
that though patients’ preferences for different treat-
ments has no clear effect on health outcomes, beliefs
about the effectiveness of the treatment they receive do.
This is particularly so for those receiving CBT. These
results could inform targeting of treatments for patients
with pain and when assessing treatments, researchers
should always take into account this expectation effect.
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